Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08GJS
|
||||
| Former ID |
DNC005861
|
||||
| Drug Name |
3-(2-Dimethylamino-propyl)-1H-indol-4-ol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527668] | ||
| Formula |
C13H18N2O
|
||||
| Canonical SMILES |
CC(CC1=CNC2=C1C(=CC=C2)O)N(C)C
|
||||
| InChI |
1S/C13H18N2O/c1-9(15(2)3)7-10-8-14-11-5-4-6-12(16)13(10)11/h4-6,8-9,14,16H,7H2,1-3H3
|
||||
| InChIKey |
GRWDWEFPYLWISL-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [527668] | |
| 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [527668] | ||
| 5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [527668] | ||
| WikiPathways | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | ||||
| Monoamine GPCRs | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
| SIDS Susceptibility Pathways | |||||
| GPCR downstream signaling | |||||
| GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.